FDA Clearance Tracker · P150017-S015
Cartiva Synthetic Cartilage Implant (SCI)
Last checked: Nov 20, 2026Latest source record: Dec 10, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Dec 10, 2021
Approved
Time to decision
163 days
Received Jun 30, 2021. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P150017-S015
- Device name
- Cartiva Synthetic Cartilage Implant (SCI)
- Applicant
- Cartiva, Inc.
- Applicant location
- Alpharetta, GA
- Received
- Jun 30, 2021
- Decided
- Dec 10, 2021
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P150017
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for a manufacturing site located at Building C, 11576 Memphis-Arlington Road, Arlington, Tennessee 38002 as a secondary manufacturing and packaging site of Cartiva SCI devices.
Source documents
Other decisions for Cartiva, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K192156 · Decided Sep 4, 2019 · 26 days after receipt
Device type: Instruments Designed For Press-Fit Osteochondral Implants (QBO) · Orthopedic Surgery
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.